Skip to content

Bio-Rad Hemoglobin Detector

by Bio-Rad

510(k) K882051

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK882051 Date1 Aug 1988ClearedStatusActive

Official records

From the FDA record

Received by the FDA
16 May 1988
FDA decision
1 Aug 1988 (Substantially Equivalent)
FDA review time
77 days from receipt to decision

From the FDA 510(k) record K882051 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
LCP
Device class
Class II
Regulation
21 CFR Part 864.7470
Advisory committee
Hematology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 6 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Bio-Rad Hemoglobin Detector is a device used for automated hemoglobin testing. It is designed to perform HbA1c and HbA2/F/A1c testing on a single platform, providing comprehensive analysis in a compact footprint.

The device is supplied for laboratory use and is regulated under FDA 510(k) clearance with a product code of LCP. It is a Class II device intended for hematology applications, with dimensions of 15.8 inches wide by 21 inches deep by 19.5 inches high.

Similar devices

Other devices filed under FDA product code LCP (Assay, Glycosylated Hemoglobin).

Other devices from Bio-Rad

See all devices from Bio-Rad →